Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients

BACKGROUND: Combination chemotherapy with oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) has become a standard regimen for colorectal cancer. An increase of adverse events with combination chemotherapy is predicted in elderly patients, and it remains controversial whether they should receive th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sugimoto, Shinichi, Katano, Kuniyuki, Kanazawa, Akiyoshi, Yoshimura, Hiroshi, Kidani, Akihiko, Takeda, Hiroshi, Makino, Masato, Ozaki, Nobuhiro, Tanaka, Tsuneo, Ikeguchi, Masahide
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2009
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2731734/
https://ncbi.nlm.nih.gov/pubmed/19664225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-28-109
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge